An interventional study of Sucrose and Aspartame in Obesity, sponsored by University of Hull. Completed. Open to female participants aged 20 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-01-28.
Sponsored by University of Hull · Not applicable, Interventional, and Basic science
This study partially replicates two previous studies with normal weight women, and overweight women. Both found that women could compensate for sucrose added to the diet in carbonated soft drinks (4 x250ml total1800 kJ per day) when it was given blind over a period of 4 weeks. The hypothesis is that this applies also to obese women, who will not gain weight, increase overall energy intake in the diet, or eat differently whilst consuming sucrose. 42 participants shall be randomly assigned to either be given carbonated drinks that contain sucrose, or drinks that are artificially sweetened.
1,223 studies on the registry are indexed under Body Weight; 131 are open to participants now.
This study's enrollment of 41 is below the median of 64 across 947 interventional studies indexed under Body Weight.
Browse Body Weight studies →University of Hull is the lead sponsor of 33 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Receives sucrose
Dietary Supplement: Sucrose
Receives Aspartame sweetened drinks
Dietary Supplement: Aspartame
Sucrose in carbonated soft drinks (4 x250ml total1800 kJ per day)
Also known as: Irn Bru
Intensely sweetened soft drink (no energy content)
Also known as: Diet Irn Bru
Change in body weight from baseline
Time frame: 4 weeks
Mean daily dietary intake estimated from unweighed food diaries
Time frame: 4 weeks
Rated Mood
Mood was assessed 4 times per day over the study period
Time frame: 4 weeks
No study locations are listed for this record.
This study is completed, as verified in Jan 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Hull